HuGE Literature Finder
Records 1-2
Phase II study of fixed-dose-rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced bile duct cancer: Daegu Gyeoungbuk Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Feb 29 (4_suppl): 280. Ryoo H, Bae S, Kim M, Lee K H, Song H, Chae Y, Lee W, Baek |
Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China.
Carcinogenesis 2008 Jan 29 (1): 100-5. Huang Wen-Yi, Gao Yu-Tang, Rashid Asif, Sakoda Lori C, Deng Jie, Shen Ming-Chang, Wang Bin-Sheng, Han Tian-Quan, Zhang Bai-He, Chen Bingshu E, Rosenberg Philip S, Chanock Stephen J, Hsing Ann |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: